AKAP13: A-Kinase Anchoring Protein 13

A scaffold protein regulating RhoA and PKA signaling in cardiovascular and cancer biology

Gene Information Card

Symbol AKAP13
Full Name A-kinase anchoring protein 13
Gene Type protein-coding
Chromosomal Location 15q25.3
NCBI Gene ID 11214 ncbi.nlm.nih.gov/gene/11214
Ensembl ID ENSG00000170776
UniProt ID Q12802
OMIM ID 604686
HGNC ID 369
Aliases BRX, LBC, Ht31, PROTO-LB, c-lbc, AKAP-Lbc

Description

AKAP13 encodes a member of the A-kinase anchoring protein (AKAP) family. The protein functions as a scaffold that binds protein kinase A (PKA) and also acts as a guanine nucleotide exchange factor (GEF) for RhoA, thereby regulating cytoskeletal dynamics, gene transcription, and cell proliferation. It is involved in cardiac development, vascular function, and oncogenic signaling.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Dilated cardiomyopathy Disruption of AKAP13-mediated RhoA signaling impairs cardiac contractility OMIM, NCBI
Breast cancer Overexpression and gain-of-function mutations in AKAP13 promote RhoA activation and cell proliferation COSMIC, NCBI
Colorectal cancer Somatic mutations in AKAP13 alter GEF activity and contribute to tumorigenesis COSMIC, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 45.2 High
Skeletal muscle 32.1 Medium
Brain 18.7 Medium
Lung 12.3 Low
Liver 8.5 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 62.4 High expression
HeLa 41.0 Medium expression
MCF7 55.8 High expression (breast cancer)
HCT116 38.2 Medium expression (colorectal cancer)
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.2570A>G (p.Gln857Arg) Missense 0.02% (gnomAD) Alters RhoA GEF activity
c.3124C>T (p.Arg1042Trp) Missense 0.01% (COSMIC) Gain-of-function in breast cancer
c.4519_4520insA Frameshift <0.01% (ClinVar) Loss-of-function in dilated cardiomyopathy
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations reduce RhoA GEF activity, impairing cardiac contractility and leading to dilated cardiomyopathy.

Gain of Function (GOF)

Missense mutations (e.g., p.Arg1042Trp) enhance RhoA activation, promoting cell proliferation and tumorigenesis in breast and colorectal cancers.

Dominant Negative (DN)

Not well characterized; some truncating mutations may exert dominant-negative effects by disrupting PKA anchoring.

Gene Ontology (GO)

• GO:0005515 - protein binding • GO:0005085 - guanyl-nucleotide exchange factor activity
• GO:0007264 - small GTPase mediated signal transduction • GO:0030154 - cell differentiation
• GO:0043123 - positive regulation of I-kappaB kinase/NF-kappaB signaling

Pathways

RhoA signaling pathway (Reactome: R-HSA-194315)
PKA-mediated signaling (Reactome: R-HSA-163615)
Cardiac conduction (KEGG: hsa04260)

Protein Summary

AKAP13 is a 2,813-amino acid scaffold protein that anchors PKA and possesses intrinsic RhoA GEF activity. It localizes to the cytoplasm and plasma membrane, where it integrates cAMP/PKA and RhoA signaling to regulate actin cytoskeleton, cell migration, and gene expression. In the heart, it is essential for normal contractile function; in cancer, its overexpression or mutation drives oncogenic transformation.

Related Products

Product name Cat.No. Species Gene ID
AKAP13 Knockout HEK293 Cell Line EDJ-KQ7334 Human 11214 Details Get a Quote
AKAP13 Knockout A-549 Cell Line EDJ-KQ32420 Human 11214 Details Get a Quote
AKAP13 Knockout HCT 116 Cell Line EDJ-KQ32421 Human 11214 Details Get a Quote
AKAP13 Knockout HeLa Cell Line EDJ-KQ32422 Human 11214 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: